EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+8.64%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$7.44B
AUM Growth
+$7.44B
(+10%)
Cap. Flow
+$500M
Cap. Flow
% of AUM
6.72%
Top 10 Holdings %
Top 10 Hldgs %
25.63%
Holding
170
New
15
Increased
63
Reduced
24
Closed
16
Top Buys
| 1 |
Zymeworks
ZYME
|
$62.5M |
| 2 |
nCino
NCNO
|
$39.7M |
| 3 |
Shoals Technologies Group
SHLS
|
$37.4M |
| 4 |
Generac Holdings
GNRC
|
$36M |
| 5 |
argenx
ARGX
|
$35.8M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$52M |
| 2 |
Verisk Analytics
VRSK
|
$37M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$25.4M |
| 4 |
Okta
OKTA
|
$23.8M |
| 5 |
Neurocrine Biosciences
NBIX
|
$23.3M |
Sector Composition
| 1 | Healthcare | 35.75% |
| 2 | Technology | 29.25% |
| 3 | Industrials | 12.31% |
| 4 | Consumer Discretionary | 7.52% |
| 5 | Communication Services | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMAR
51
DELISTED
Smartsheet Inc.
SMAR
| $50.3M | 0.68% |
696,131
+259,131
| +59% | +$18.7M |
|
52
MediaAlpha
MAX
$613M
| $50.1M | 0.67% |
1,190,612
+156,053
| +15% | +$6.57M |
|
53
Brookfield Renewable
BEP
$7B
| $47.7M | 0.64% |
1,236,000
| – | – |
|
|
TPTX
54
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $45.1M | 0.61% |
578,000
+73,000
| +14% | +$5.7M |
|
55
Sutro Biopharma
STRO
$85.6M
| $44.1M | 0.59% |
2,370,975
| – | – |
|
56
BridgeBio Pharma
BBIO
$9.91B
| $43.4M | 0.58% |
712,197
| – | – |
|
|
BPMC
57
DELISTED
Blueprint Medicines
BPMC
| $40.6M | 0.55% |
461,712
-288
| -0.1% | -$25.3K |
|
|
58
nCino
NCNO
$3.55B
| $39.7M | 0.53% |
+662,500
| New | +$39.7M |
|
59
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.46B
| $39.3M | 0.53% |
700,200
| – | – |
|
60
Brookfield Renewable
BEPC
$5.92B
| $38.1M | 0.51% |
908,919
-69,438
| -7% | -$2.91M |
|
61
Novanta
NOVT
$4.05B
| $37.7M | 0.51% |
280,000
| – | – |
|
|
62
Verisk Analytics
VRSK
$37.5B
| $37.2M | 0.5% |
213,000
-211,800
| -50% | -$37M |
|
63
Cullinan Oncology
CGEM
$456M
| $36.2M | 0.49% |
1,440,145
+227,590
| +19% | +$5.71M |
|
64
Immunovant
IMVT
$2.91B
| $35.6M | 0.48% |
3,370,994
+897,994
| +36% | +$9.49M |
|
|
BCYC
65
Bicycle Therapeutics
BCYC
$492M
| $35.3M | 0.47% |
1,163,471
+751,633
| +183% | +$22.8M |
|
66
Clearway Energy Class C
CWEN
$3.38B
| $34.5M | 0.46% |
1,303,400
| – | – |
|
|
ALLK
67
DELISTED
Allakos
ALLK
| $34.2M | 0.46% |
401,000
+84,000
| +26% | +$7.17M |
|
68
Lennox International
LII
$19.1B
| $33.3M | 0.45% |
95,000
| – | – |
|
69
MongoDB
MDB
$25.5B
| $32.3M | 0.43% |
89,355
+375
| +0.4% | +$136K |
|
70
ADC Therapeutics
ADCT
$370M
| $31.9M | 0.43% |
1,311,990
+397,251
| +43% | +$9.67M |
|
71
Nurix Therapeutics
NRIX
$723M
| $31.8M | 0.43% |
1,200,000
| – | – |
|
72
XPO
XPO
$14.8B
| $30.8M | 0.41% |
636,107
| – | – |
|
73
Cognex
CGNX
$7.43B
| $30.2M | 0.41% |
359,000
| – | – |
|
74
Monolithic Power Systems
MPWR
$39.6B
| $28.9M | 0.39% |
77,459
+3,300
| +4% | +$1.23M |
|
75
Skyworks Solutions
SWKS
$10.9B
| $28.4M | 0.38% |
148,047
+500
| +0.3% | +$95.9K |
|